alexa Michel Sickenberg | OMICS International
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Michel Sickenberg

member Medical Photonics Group, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland

Biography

Dr. Sickenberg received his MD title in 1995 in the Jules Gonin hospital in
Lausanne, Switzerland, where he was a resident and chief resident as
ophthalmologist and ophthalmic surgeon. He was a principal investigator for the
development of the Visudyne phototherapy treatment for various forms of wet
macular degeneration between 1995 and 2000. In 2006, he introduced Avastin in
Switzerland as the first anti-VEGF substance for intravitreal injections in various
forms of macula edema. In 2011, he introduced a new method to Switzerland to
regenerate diverse forms of atrophic macula diseases using bioregulator peptides.
As of 2000, he runs a private ophthalmic practice in Lausanne.

 

Research Interest
Publications

The Role of Photodynamic Therapy in Non-malignant and Malignant Eye Disorders

Patrycja Nowak-Sliwinska, Andrea Weiss, Michel Sickenberg, Arjan W Griffioen and Hubert van den Bergh

Review Article: J Anal Bioanal Tech 2013, S1:007

DOI: 10.4172/2155-9872.S1-007

Global Speakers in the subject

Global Experts in the subject

Top